Immunic to Host MS R&D Day and Participate in Investor Conferences in April [Yahoo! Finance]
Immunic, Inc. (IMUX)
Company Research
Source: Yahoo! Finance
molecule therapies for chronic inflammatory and autoimmune diseases, today announced that it will host a Multiple Sclerosis (MS) Research and Development (R&D) Day and participate in the following investor conferences in April: April 9 Immunic's MS R&D Day Management of Immunic, including Daniel Vitt , Ph.D., Chief Executive Officer and President, Andreas Muehler , M.D., M.B.A. Chief Medical Officer and Hella Kohlhof , Ph.D, Chief Scientific Officer, will be joined by renowned key opinion leaders to discuss the latest developments in the MS landscape as well as recent preclinical and clinical data supporting the neuroprotective potential of Immunic's late-stage clinical asset, first-in-class Nurr1 activator, vidofludimus calcium. The MS R&D Day will take place on Tuesday, April 9, 2024 , from 10:30 am to 12:30 pm PST in-person at the Hotel Nikko in San Francisco . To register, please RSVP by sending an email to: ir@imux.com April 15-17 Accelerating Bio-Innovation 2024 UK. Dr. Vitt
Show less
Read more
Impact Snapshot
Event Time:
IMUX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMUX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMUX alerts
High impacting Immunic, Inc. news events
Weekly update
A roundup of the hottest topics
IMUX
News
- Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role [Yahoo! Finance]Yahoo! Finance
- Immunic, Inc. (NASDAQ: IMUX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- Immunic, Inc. (NASDAQ: IMUX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- ATOS, SMR and EIGR are among pre market gainers [Seeking Alpha]Seeking Alpha
- Immunic, Inc. (NASDAQ: IMUX) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $10.00 price target on the stock.MarketBeat
IMUX
Earnings
- 11/14/23 - Beat
IMUX
Sec Filings
- 4/23/24 - Form DEF
- 3/8/24 - Form 8-K
- 3/6/24 - Form 4
- IMUX's page on the SEC website